Cargando…
Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis
Tuberculosis is a severe infectious disease caused by Mycobacterium tuberculosis and is a significant public health concern globally. The World Health Organization (WHO) recommends a combination regimen of several drugs, such as rifampicin (RIF), isoniazid (INH), pyrazinamide (PZA), and ethambutol (...
Autores principales: | Shao, Liqun, Shen, Shu, Liu, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355142/ https://www.ncbi.nlm.nih.gov/pubmed/35935487 http://dx.doi.org/10.3389/fbioe.2022.941077 |
Ejemplares similares
-
PLGA-Based Drug Delivery Systems for Remotely Triggered Cancer Therapeutic and Diagnostic Applications
por: Shen, Xue, et al.
Publicado: (2020) -
PLGA-based drug delivery systems in treating bone tumors
por: Qiu, Enduo, et al.
Publicado: (2023) -
Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances
por: Jia, Yufeng, et al.
Publicado: (2022) -
Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy
por: Zhao, Bonan, et al.
Publicado: (2022) -
Recent advances in aptamer-based targeted drug delivery systems for cancer therapy
por: Gao, Fei, et al.
Publicado: (2022)